SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: luis a. garcia who wrote (253)7/10/1997 11:55:00 PM
From: John Zwiener   of 1115
 
Hi Luis,
Lidak would only (I hope) initiate phase 3 studies on using lidakol on kaposi's sarcoma if they thought it worked. Same thing with LMI.

How did I come up with 500 million for Lidakol? It seems like a conservative number for a drug with the potential it seems to have, IF the phase 3 studies come through.

Those with a background knowledge of herpes infections, and the natural course of an outbreak might be able to make an educated guess as to whether this drug really does work or not. From the stuff supplied by lidakol pharm., it would seem to work. If not, then I might feel we were lead on. Heck, why not say it, I know we were lead on.

This investment is based on if you feel you believe what management is telling you. Period. If they are being accurate, then this is a very good drug. From watching biotechs, I have learned that these companies release data that somehow does not jive with the phase 3 data. I only continue to follow this company because they had a good story (expaination) for the prior failure. It made sense to me because ..............We have to wait.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext